Offer - Urjas Oil for just ₹ 1 X
Romilast L 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Romilast L 5 Tablet safe for pregnant women?
Romilast L has many dangerous side effects in pregnant women. If you are pregnant, do not consume Romilast L without medical advice.
Is the use of Romilast L 5 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Romilast L. So it is adviced to consult the doctor before using it.
What is the effect of Romilast L 5 Tablet on the Kidneys?
In the absence of any scientific study on the side effects of Romilast L on kidney, information on safety of Romilast L for kidney is unavailable.
What is the effect of Romilast L 5 Tablet on the Liver?
There is no research available on the side effects of Romilast L on the liver. Therefore, its impact is unknown.
What is the effect of Romilast L 5 Tablet on the Heart?
No research work has been carried out till date on effects of Romilast L on heart. So it is not known whether taking Romilast L will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Romilast L 5 Tablet unless your doctor advises you to do so -
Is this Romilast L 5 Tablet habit forming or addictive?
Romilast L 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Romilast L 5 Tablet as you may feel sleepy.
Is it safe?
Yes, Romilast L 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Romilast L 5 Tablet for mental disorders.
Interaction between Food and Romilast L 5 Tablet
Due to the absence of research, it is difficult to say how Romilast L 5 Tablet and food will interact.
Interaction between Alcohol and Romilast L 5 Tablet
Information about the interaction of Romilast L 5 Tablet and alcohol is not currently available because this topic has not been researched yet.
Romilast L works by blocking the action of histamine which is responsible for allergies in our body. This helps to relieve symptoms of allergies, such as a runny nose, sneezing, and redness, watery, itchy eyes. This drug also helps to relieve itching caused due to urticaria (hives).
Yes, Romilast L can be taken with montelukast. As per clinical studies, no harmful interaction has been reported after taking them. However, do not take it without doctors advise. A fixed-dose combination of [Medicinie] and montelukast is available in the market which is used in the treatment of respiratory tract inflammation.
Absorption of Romilast L is not affected by food and hence can be taken with or without food. Preferably it should be taken in the evening. However, you are recommended to take it as per the doctor's instructions.
No, taking Romilast L does not cause high blood pressure. However, if you are experiencing fluctuations in blood pressure while taking this drug. Do not delay, inform your doctor immediately.
Yes, Romilast L can cause stomach upset. It is a common side effect of this drug. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd